Intended Use

Fetal EchoScan is a machine learning-based computer-assisted diagnosis (CADx) software device indicated as an adjunct to fetal heart ultrasound examination in pregnant women aged 18 or older undergoing second-trimester anatomic ultrasound exams.

Technology

The device is a cloud-based software-only AI that uses neural networks to detect suspicious fetal cardiac radiographic findings from fetal ultrasound video clips containing standard cardiac views (4-chamber, left and right ventricular outflow tracts). It outputs frame-by-frame classifications as present, absent, or inconclusive for each suspicious finding.

Performance

Performance was validated using 877 fetal ultrasound exams from multiple centers with pediatric cardiologist truthing. Standalone testing showed high sensitivity (up to 98.7%) and specificity (up to 100%) for detecting suspicious findings. A multiple-reader study showed a significant improvement in reader diagnostic accuracy, sensitivity, and specificity when aided by the software.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    8/7/2024

    3 months
  • 2

    FDA Approval

    11/14/2024

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.